Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423483 · ClinicalTrials.gov registry record · Phase 2
Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents
A Phase 2 study of Suicide, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT05423483 is a Phase 2 study of Suicide that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 61 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05423483, a Phase 2 study of Suicide, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Objective: to develop a phone-based intervention to aid parents of suicidal adolescents to adhere to lethal means safety. Lethal means counseling is the practice of educating patients and their families about limiting access to items that can be used to attempt suicide. Though lethal means counseling is standard practice in treating suicidal patients, there is little experimental literature related to its utilization across different providers and its efficacy. Further, there is a significant gap in the literature on lethal means counseling as it relates to adolescents. The proposed project will investigate a novel text message-based intervention aimed to promote lethal means safety.
Conditions Studied
Interventions
- BEHAVIORAL Safe Home Text Message Reminders
Study Locations (1)
Texas
- Children's Health - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2022-09-08 |
| Est. Completion | 2024-07-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423483
The ClinicalTrials.gov registry entry for NCT05423483 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Safe Home Text Message Reminders is the first listed.
NCT05423483 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05423483 about?
NCT05423483 is a clinical study titled "Developing an Intervention to Promote Lethal Means Safety in Suicidal Adolescents". Study Objective: to develop a phone-based intervention to aid parents of suicidal adolescents to adhere to lethal means safety. Lethal means counseling is the practice of educating patients and their families about limiting access to items that can be used to attempt suicide. Though lethal means co...
What is the current status of trial NCT05423483?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 61 participants. The study started on 2022-09-08. Estimated completion is 2024-07-19.
What conditions does trial NCT05423483 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05423483?
The interventions under investigation include: Safe Home Text Message Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT05423483?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05423483 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suicide Risk Interventions
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Ketamine & Crisis Response Plan for Suicidal Ideation in the ED
RECRUITING · Phase 2
-
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
RECRUITING · Phase 2
-
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
RECRUITING · Phase 2
-
Evaluation of a School-Based Training Program for Suicide Prevention
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.